ARCHIVES

Toxic Substance Act Would Affect Cancer Program

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | March 21, 1975

Download PDF Visit The Full Archive

Related Articles

Pressure Grows On Upton To Reveal Plans

November 23, 1979

Robert Weinburger, Ernst Wynder Win Top Milken Awards

November 2, 1990

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

June 3, 2005

NCI Program: DOD’s TRICARE To Cover Patient Costs In NCI Prevention, Early detection Trials

September 10, 1999

FDA Approvals: Cobas HPV Test Approved For Primary Cervical Screening

April 25, 2014

Avastin Increases Overall Survival 3.7 Months

February 22, 2013